Earnings Preview: AGIO to Report Financial Results Pre-market on May 01

Moomoo NewsApr 25 21:00 ET

BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Cuts Target Price to $52

Moomoo NewsApr 18 03:31 ET · Ratings

Express News | Agios Pharmaceuticals Inc : BofA Global Research Cuts Price Objective to $52 From $54

ReutersApr 17 09:38 ET

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

GlobeNewswireMar 5 17:52 ET

Celldex Therapeutics and Agios Pharmaceuticals to Present at March 2025 Investor Conferences

YolowireMar 5 15:32 ET

J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Raises Target Price to $43

Moomoo NewsMar 3 11:32 ET · Ratings